Finance

Ionis: The Sell-Off Is Overdone (NASDAQ:IONS)


Ionis Pharmaceuticals (NASDAQ:IONS), a leader in development of antisense medicines, saw its stock slump 50% in March after abandoning its lead …

Read more

Show More

Related Articles

Back to top button